News and Media

Latest News Release
11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Announces Redemption Price for Outstanding Notes
06/29/2017

DUBLIN, Ohio, June 29, 2017 /PRNewswire/ -- Cardinal Health today announced a redemption price of $1,002.55 per $1,000 for its previously reported "make-whole" redemption of all of its outstanding 1.7 percent notes, which are due in 2018 (CUSIP No. 14149Y AX6). The redemption price was calculated in accordance with the terms of the notes being redeemed.

In addition to the redemption price, redeeming holders of such notes will receive approximately $5.01 in accrued and unpaid interest per $1,000 principal amount of notes being redeemed. Therefore, the total amount paid per $1,000 principal amount of notes being redeemed will be approximately $1,007.56, reflecting a redemption price of $1,002.55, plus approximately $5.01 in accrued and unpaid interest. 

The redemption date, as previously announced, is July 1, 2017.  Payment of the redemption price, as well as any unpaid and accrued interest, will occur on Monday, July 3, 2017, the first business day following the redemption date, in accordance with the terms of the indenture governing the notes.

The notes were issued on Feb. 22, 2013, pursuant to the June 2, 2008, indenture by and between the company and The Bank of New York Mellon Trust Company, formerly known as The Bank of New York Trust Company, as trustee.

This press release shall not constitute a notice of redemption of the notes.

About Cardinal Health 
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. Cardinal Health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. Because Cardinal Health helps ensure pharmacists and the consumers they serve have access to medications they need while working to help prevent prescription drug diversion, the company and its education partners created Generation Rx, a national program to help prevent the misuse of prescription medications. Backed by nearly 100 years of experience, with more than 40,000 employees in nearly 60 countries, Cardinal Health ranks among the top 25 on the Fortune 500. For more information, visit cardinalhealth.com, follow @CardinalHealth on Twitter and connect on LinkedIn at linkedin.com/ company/cardinal-health.

SOURCE Cardinal Health, Inc.

For further information: Media: Corey Kerr, (614) 757-3383, corey.kerr@cardinalhealth.com; Investors: Lisa Capodici, (614) 757-5035, lisa.capodici@cardinalhealth.com
More Company News
12/20/2024

Cardinal Health poised to become the first company to offer cGMP-compliant material at commercial scale by year end DUBLIN, Ohio, Dec. 20, 2024 – Cardinal Health (NYSE: CAH) today announced the...

12/19/2024

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2025 on January 30, prior to the opening of trading on the New York Stock Exchange. The company...

12/03/2024

ION accelerates development of Navista, integrating more than 100 providers at more than 50 community-based sites across 10 states into oncology practice alliance. DUBLIN, Ohio, Dec. 3, 2024 –...

11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

View all company news »